BiVictriX is a rapidly emerging biotechnology company applying a novel approach to develop safer, more effective cancer therapies.
| Industry: | Health Care |
| Sector: | Health Care |
| Website: | bivictrix.com |
| Twitter: | @BiVictriX |
| Exchange: | LSE |
| Admission date: | 10 Aug 2021 |
| Market: | Aim |
| Region: | Europe |
| 31 Mar 2023 | Publication of Annual Report and Notice of AGM |
| 4 May 2023 | Annual General Meeting |